chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her 73 year old husband with iodine allergy "discovered 26 years ago" and neuropathic pain.  It was reported that the patient had injuries because of a car accident in 1981 and developed neuropathy pain 5 years ago "but it is light pain".  On 15-JAN-2008, the patient was vaccinated with a dose of Zostavax (Oka/Merck).  Concomitant therapy included LYRICA, lovastatin (manufacturer unknown), "trismeterene", amlodipine besylate, "denazetril", and clonazepam.  The reporter stated that the patient experienced neuropathy pain triple times the usual pain "one hour after receiving Zostavax vaccine".  The patient was brought to the hospital.  A lot number was not provided.  The reporter also stated that the patient did not have a history of shingles.  The patient also had "extreme low blood pressure" and there were changes in his speech after receiving Zostavax (Oka/Merck).  It was reported that there was "test to check blood pressure".  The patient was recovering from the pain.  Outcome was reported as recovering.  The patient sought medical attention: "see the physician".  There was no product quality complaint.  Additional information has been requested.
flu lungs fill with fluid; Initial information received on 08-Dec-2020 regarding an unsolicited valid non-serious social media case received from a non-healthcare professional (consumer).  This case involved an adult patient of unknown gender for whom it was reported had experienced flu lungs fill with fluid, while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, unknown latency, the patient had experienced flu lungs fill with fluid (flu).  No relevant laboratory details were provided.  It was not reported if the patient received a corrective treatment.  The outcome of the event was unknown.  There will be no information available on the batch number for this case.
This spontaneous report as received from an Office Manager refers to unknown number of patients of unknown age. It was reported that since approximately 05-SEP-2012, doses of improperly stored VAQTA might have been administered to patients (doses, route and lot numbers not reported). The vaccine was exposed to 24F for more than two excursions since 05-SEP-2012, the exact period of time that the vaccines were exposed to 24F is uncertain at this time, but the number of excursions totaled more than 2. This is one of several reports received from the same reporter (MARRS # 1210USA002523, 1210USA013248, 1210USA013250). Additional information has been requested.
9PM tympanic temp 103.9, fussy and crying until midnight, then went to sleep around 1 or 2AM.  Mom gave tylenol and fever dropped to 101, mom notified our office at 10:45AM on 05/03/2006 and was instructed to bring patient in office to check if anything else could be wrong. Exam did not reveal any abnormalities.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Information regarding relevant medical history and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with improperly stored RECOMBIVAX HB (dose and route unspecified, strength reported as 0.5 mcg/0.5 ml, lot # K010535 with expiration date of 27-AUG-2016). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Patient is a 41 y.o. female, reported history of asthma, obesity, polysubstance use, is transferred to the hospital via EMS in cardiac arrest.  Per EMS report, the patient was found in an apartment complex by a neighbor unconscious.  The initial report was that she was breathing however EMS was called back and then told that she was not breathing and not responsive.  Estimated downtime was between 5 and 8 minutes before paramedics arrived and initiated CPR.  Due to the patient's body habitus, it did take approximately 15 minutes to get the patient transported to the hospital.  3 rounds of epinephrine were given in the field.  Her rhythm has been asystole prior to getting to the emergency department.  Intraosseous access is obtained.  There is an OPA in place.
brain fog feeling; extremely uncomfortable; left arm where the injection was given until the bottom of left breast, the whole area on the left side was itchy; low energy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (brain fog feeling), DISCOMFORT (extremely uncomfortable), VACCINATION SITE PRURITUS (left arm where the injection was given until the bottom of left breast, the whole area on the left side was itchy) and FATIGUE (low energy) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced FEELING ABNORMAL (brain fog feeling), DISCOMFORT (extremely uncomfortable), VACCINATION SITE PRURITUS (left arm where the injection was given until the bottom of left breast, the whole area on the left side was itchy) and FATIGUE (low energy). On 20-Apr-2021, DISCOMFORT (extremely uncomfortable) had resolved. At the time of the report, FEELING ABNORMAL (brain fog feeling), VACCINATION SITE PRURITUS (left arm where the injection was given until the bottom of left breast, the whole area on the left side was itchy) and FATIGUE (low energy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was not reported. Treatment medication included pain relieving roll-on.   This case was linked to MOD-2021-083044 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: Non Significant FU received on 03-aug-2021- patient did not seek medical treatment from her HCP and requested to send forms via mailing address; Sender's Comments:  MOD-2021-083044:first dose
Pt vaccinated with Recombivax HB developed encephaloymelitis admitted to hosp w/vertigo, ataxia, rt sided weakness and rt hypalgesia. Also possible Multiple sclerosis.
Reporter states pt did not seroconvert p/recvd Engerix-B series; all injections were administered IM;
Left upper inner arm redness, warmth.  Headache, body aches, joint pain, scratchy throat.
Worsening depression (2+ weeks - ongoing). Fatigue (2+ weeks - ongoing) Increased anxiety (1-2 weeks) Swollen lymph node in armpit on the side shot was given (2+ weeks - ongoing) Fever (1 day) Chills (1 day) Body aches (1 day) Nausea (1 day) Headache (1 day)
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with PNEUMOVAX 23 lot # K007826, (route, dose and expiration date not reported). On an unknown date, 24 to 48 hours after being administered PNEUMOVAX 23, the patient experienced hot and painful injection site reaction. The patient sought medical attention and was diagnosed with cellulitis at the injection site. At the time of the report the outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
Itchy rash/hives started on chest and moved to all skin surfaces. Patient has tried Benadryl po and calamine lotion, without relief. Seen at Clinic today and given loratidine and hydrocortisone cream.
Right Arm injection site reaction after SHINGRIX given on 6/22/18 presented to the Pharmacy on 6/24/18. Raised red spot about 2 inches long and 1.5 inches wide with pain surrounding the entire area up to the top of her shoulder.
systemic rash on torso and arms; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of RASH (systemic rash on torso and arms) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included INTRAUTERINE CONTRACEPTIVE DEVICE (IUD NOS) for Contraception.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (systemic rash on torso and arms). At the time of the report, RASH (systemic rash on torso and arms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication included IUD but was not taking any medications. Treatment medication was not reported.  The systemic rash developed the last 24hrs (torso and arms) and was not itchy.
soreness; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness), PYREXIA (Fever) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (soreness), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, MYALGIA (soreness), PYREXIA (Fever) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  Treatment medication was not provided by the reporter  It was reported that the Patient had experienced classic symptoms soreness, fever, headache for a day and a half
Initial report received from a healthcare professional on 05 June 2013. A female patient of unspecified demographics, whose illness at the time of vaccination and pre-existing medical conditions were unknown and concomitant medications were not reported, had received a dose of Tetanus vaccine from unknown manufacturer (Lot number was unknown, route and anatomical site of vaccination was not reported) many years ago on an unspecified date many years ago. On an unknown date, the patient complained of entire body aches after vaccination. Laboratory investigations and corrective treatments were not reported. At the time of this report, the outcome of event was unknown. List of documents held by the sender: None.
6 days p/1st Recombivax inject onset of fever 101, nausea, vomiting, body aches lasted only 24 hrs;
Patient presented with open blister on left arm on 6/18/16 at 5:56 pm. Patient stated that he had thought there was a blister at the injection site and that it ripped when he scratched it. The skin did not look infected. Keep clean and apply ATB ointment. Told patient we would follow up.
On 06/02/2000, the patient did not have an appetite and had a fever. The patient sought unspecified medical attention. Additional information has been requested.
8:10 am mother called, stated child broke out in a rash all over except on his arms and legs last night. Rash is red and still present. Was treated x 1wk ago for a cold-off meds a week now. Had 3rd PCV7 vaccine yesterday. Mother denies any other problems other then rash. EM her to call her pediatrician and speak to his nurse about rash. Not on any medicine at present.
got a dose of the Pfizer Covid 19 orange cap formulation instead of the recommended maroon cap formulation; got a dose of the Pfizer Covid 19 orange cap formulation instead of the recommended maroon cap formulation; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A 4-year-old patient received BNT162b2 (BNT162B2), as dose 2 (orange cap), single (Batch/Lot number: unknown) at the age of 4 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), OVERDOSE (non-serious), outcome "unknown" and all described as "got a dose of the Pfizer Covid 19 orange cap formulation instead of the recommended maroon cap formulation".  Additional information: Caller was a physician reporting that a patient just turned 4 years old. Caller stated, that was the patient's second dose so she asked if she could still get the 3rd dose of the maroon cap 8 weeks later.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Employee reported headache, flushing, and a sweaty feeling. He was taken to ED for evaluation and treatment.
Approximately six hours after receiving my second dose of the vaccine on 2/11/2021, I had chills, nausea, joint pain, a feeling of heaviness like I couldn't move or walk, a migraine. Most of those symptoms lasted for 36 hours, however the headache and the chills remained. The following Tuesday (2/16) I starting having severe difficulty breathing and was gasping often. I tried my inhaler and that did nothing. This persisted. On 3pm Thurs (2/18) I started feeling dizzy and by 4:30pm I could not stand. Went to the doctor on Friday (2/19) with a fever of about 100, inability to walk without assistance. I've also been having memory problems. I went to a balance center EMT on 3/10 for a repositioning procedure and I still Additional information for Item 18: feel dizzy, so there were no results to date.
Rash on right torso (belt line) side of the back of and front of thighs and buttocks
This spontaneous report was received from a medical assistant and refers to an unspecified patient of unknown age and gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 24-APR-2017, the patient was vaccinated with the fourth dose of GARDASIL, lot number M040412 with expiration date 30-JUN-2019, (dose, route and anatomical location were not reported) for prophylaxis. No adverse effects were reported. Additional information has been requested.
Heptatis Ainfection; Incomplete course of vaccination; This case was reported by a consumer via call center representative and described the occurrence of hepatitis a in a adult female patient who received HAV (Havrix adult) for prophylaxis.   Co-suspect products included HAV (Havrix adult) for prophylaxis.   On an unknown date, the patient received the 1st dose of Havrix adult and the 2nd dose of Havrix adult. On an unknown date, several years after receiving Havrix adult and not applicable after receiving Havrix adult, the patient experienced hepatitis a and incomplete course of vaccination. On an unknown date, the outcome of the hepatitis a and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the hepatitis a to be related to Havrix adult.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the vaccine years ago and experienced hepatitis a. Till the time of reporting the patient not receive the booster dose which led to incomplete course of vaccination. The patient stated that the health department told her to just get the booster vaccination, but the CDC told her to get the Havrix series again.
This spontaneous report as received from a pharmacy technician refers to a 24-year-old patient of unknown gender. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant medications were not reported. On 06-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry date: 23-AUG-2019) (dose, frequency and route were not reported) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter.; Sender's Comments: US-009507513-1802USA001558:
This is a spontaneous report from a contactable physician through a Pfizer sales representative. An adolescent male patient of an unspecified age received TRUMENBA on an unknown date, at single dose, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced fever like symptoms and injection site pain with difficulty moving. Clinical outcome of the events was unknown at time of this report. No follow-up attempts are possible, information about lot number cannot be obtained.
Pt to ER via EMS from home 5/21 for c/o generalized weakness and fatigue with a dry cough and tests positive for COVID upon admission. EMS states pt has been exposed to COVID, pt is A&Ox3, slightly confused per baseline with fatigue with a dry cough. 5/23 a change in mentation was mentioned by team, vital signs stable with slight decrease in BP. Pt received a+ox4 c no c/o pain throughout. 5/24 pt in bed AOx4, on RA not in distress, denies pain or sob, with ongoing IV fluid infusing well, IV ABX given as ordered, remains on isolation precaution, continue with the plan of are, safety maintained. Discharged home 5/25.
Left arm Prevnar. Right arm deltoid DTaP swelling, redness, warmth + pain. Tx: Benedryl + Motrin
Initial unsolicited report received from a physician via Pfizer under reference number 2016554271 on 09 February 2017. This case involves a female patient (age not reported) who was vaccinated with a dose of TETANUS TOXOID (batch number, expiry date, dose, route and site of administration were not reported) on unspecified date. Patient's medical history and concomitant medications were not reported. On unspecified date, following the vaccination the patient experienced allergy. Lab data and corrective treatment was not reported. The outcome of the event was not reported. List of documents held by sender: none.
This spontaneous report was received from a medical assistant concerning to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 19-NOV-2015, the patient was vaccinated with improperly stored ROTATEQ oral liquid, lot # L008574, expiration date 22-NOV-2016, (dose and dose number were unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Patient started to feel dizzy, shaky and said she was having some trouble breathing about 15 minutes after receiving the vaccine. She had been drinking water but did not have anything to eat that morning. Upon talking to patient she did not seem to be out of breath and could talk normally. We had her sit and try drinking some orange juice but it did not seem to improve her symptoms. She eventually asked to take a walk and get a small snack. A pharmacy technician went with her and after sitting back down and eating something she was started to feel better. About 10 minutes after eating the patient was feeling fine. This was about 1 hr and 30mintues after receiving the vaccine.
wanted to report a possible adverse reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (wanted to report a possible adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (wanted to report a possible adverse reaction). At the time of the report, ADVERSE REACTION (wanted to report a possible adverse reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
From her email: " Yesterday, my sons and I had our 2nd dose of the covid vaccine. I had Moderna and expected the sore arm and headache that I got however at some point during the night I got up to use the bathroom and remember feeling like everything was spinning and the next thing I knew, my husband was crouched over me asking what was wrong (he was pretty panicked). I was laying across our bathroom floor and had zero recollection of how I got there. I had serious difficulty getting up and couldn't talk. He later said my blood pressure was normal. I wouldn't imagine this is a normal reaction to a vaccine. "
Cerebral venous thrombosis, PE, stroke, left hemiparesis and encephalopathy
A day after receiving my vaccine, I noticed tingling in my fingers. I went to my doctor and they did a finger prick test. They told me to keep an eye on it and to come back if it got worse, but after a week or so it went away.
Patient received first dose of Moderna vaccine on 4/9/21. Within 15-20 minutes of being vaccinated, the patient began to experience tightening of her throat and increased blood pressure. Diphenhydramine (25mg) was given to the patient and she was continuously monitored. Patient's symptoms began to worsen (increased throat tightness, itching, increasing blood pressure), an Epipen was administered, and EMS services were called. Pt was transported to a local hospital by EMS for further treatment. Per patient, she was discharged on 4/9/21 from the hospital after being treated for an allergic reaction and increased blood pressure. She was discharged with an prescription for steroids. Recommended for patient not to continue series of Moderna vaccine due to adverse reaction from first dose.
expired vaccine given to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 500E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine given to patient) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter Treatment information was not provided. Upon follow-up it was confirmed that no adverse events to report for that patient.   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Follow up received on 02-Nov 2021 included updated query response.
HYPOTENSION 4/20/2023 DYSPNEA HYPOTENSION 4/20/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED  HYPOTENSION 4/20/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA    DM 2 W CKD, UNSPECIFIED STAGE HYPOTENSION 4/20/2023 NONISCHEMIC DILATED CARDIOMYOPATHY
01/18/22  presents to Birth Center Triage for "Induction of labor". PMHx of "Gestational diabetes, Sciatica"